{"resourceType":"MedicinalProductDefinition","id":"equilidem-basics","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tGenerated Narrative\n\t\t\t\t\u003c/b\u003e\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tId\n\t\t\t\t\u003c/b\u003e\n\t\t\t\t: equilidem-basics\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tIdentifier\n\t\t\t\t\u003c/b\u003e\n\t\t\t\t: Equilidem25\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tCombined Pharmaceutical Dose Form\n\t\t\t\t\u003c/b\u003e\n\t\t\t\t:\n\t\t\t\t\u003cspan title\u003d\"Codes: {http://example.org.uk/fhir/dosefom tablet}\"\u003e\n\t\t\t\t\ttablet\n\t\t\t\t\u003c/span\u003e\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tIndication\n\t\t\t\t\u003c/b\u003e\n\t\t\t\t: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class \u0026gt;\u003d II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tLegal Status Of Supply\n\t\t\t\t\u003c/b\u003e\n\t\t\t\t:\n\t\t\t\t\u003cspan title\u003d\"Codes: {http://example.org.uk/fhir/legalstatusofsupply POM}\"\u003e\n\t\t\t\t\tPrescription only medicine\n\t\t\t\t\u003c/span\u003e\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tClassification\n\t\t\t\t\u003c/b\u003e\n\t\t\t\t:\n\t\t\t\t\u003cspan title\u003d\"Codes: {http://www.whocc.no/atc/example B01A}\"\u003e\n\t\t\t\t\tATC: B01A\n\t\t\t\t\u003c/span\u003e\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cp\u003e\n\t\t\t\t\u003cb\u003e\n\t\t\t\t\tIngredient\n\t\t\t\t\u003c/b\u003e\n\t\t\t\t:\n\t\t\t\u003c/p\u003e\n\t\t\t\u003cul\u003e\n\t\t\t\t\u003cli\u003e\n\t\t\t\t\t\u003cspan\u003e\n\t\t\t\t\t\tEquilidonium Phosphate\n\t\t\t\t\t\u003c/span\u003e\n\t\t\t\t\u003c/li\u003e\n\t\t\t\t\u003cli\u003e\n\t\t\t\t\t\u003cspan\u003e\n\t\t\t\t\t\tCalcium Carbonate\n\t\t\t\t\t\u003c/span\u003e\n\t\t\t\t\u003c/li\u003e\n\t\t\t\u003c/ul\u003e\n\t\t\t\u003ch3\u003e\n\t\t\t\tNames\n\t\t\t\u003c/h3\u003e\n\t\t\t\u003ctable class\u003d\"grid\"\u003e\n\t\t\t\t\u003ctr\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t-\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t\u003cb\u003e\n\t\t\t\t\t\t\tProduct Name\n\t\t\t\t\t\t\u003c/b\u003e\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\u003c/tr\u003e\n\t\t\t\t\u003ctr\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t*\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\tEquilidem 2.5 mg film-coated tablets\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\u003c/tr\u003e\n\t\t\t\u003c/table\u003e\n\t\t\t\u003ch3\u003e\n\t\t\t\tCross References\n\t\t\t\u003c/h3\u003e\n\t\t\t\u003ctable class\u003d\"grid\"\u003e\n\t\t\t\t\u003ctr\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t-\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t\u003cb\u003e\n\t\t\t\t\t\t\tProduct\n\t\t\t\t\t\t\u003c/b\u003e\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\u003c/tr\u003e\n\t\t\t\t\u003ctr\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t*\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\tLink to generic equivalent\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\u003c/tr\u003e\n\t\t\t\u003c/table\u003e\n\t\t\t\u003ch3\u003e\n\t\t\t\tManufacturing/Business Operations\n\t\t\t\u003c/h3\u003e\n\t\t\t\u003ctable class\u003d\"grid\"\u003e\n\t\t\t\t\u003ctr\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t-\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t\u003cb\u003e\n\t\t\t\t\t\t\tManufacturer\n\t\t\t\t\t\t\u003c/b\u003e\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\u003c/tr\u003e\n\t\t\t\t\u003ctr\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t*\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\t\u003ctd\u003e\n\t\t\t\t\t\t\u003cspan\u003e\n\t\t\t\t\t\t\tEquiliDrugCo Inc.\n\t\t\t\t\t\t\u003c/span\u003e\n\t\t\t\t\t\u003c/td\u003e\n\t\t\t\t\u003c/tr\u003e\n\t\t\t\u003c/table\u003e\n\t\t\u003c/div\u003e"},"identifier":[{"system":"http://example.org.uk/fhir/product","value":"Equilidem25"}],"combinedPharmaceuticalDoseForm":{"coding":[{"system":"http://example.org.uk/fhir/dosefom","code":"tablet"}]},"indication":"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class \u003e\u003d II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.","legalStatusOfSupply":{"coding":[{"system":"http://example.org.uk/fhir/legalstatusofsupply","code":"POM","display":"Prescription only medicine"}]},"classification":[{"coding":[{"system":"http://www.whocc.no/atc/example","code":"B01A"}]}],"ingredient":[{"text":"Equilidonium Phosphate"},{"text":"Calcium Carbonate"}],"name":[{"productName":"Equilidem 2.5 mg film-coated tablets"}],"crossReference":[{"product":{"reference":{"reference":"MedicinalProductDefinition/genericEquilidonium"}}}],"operation":[{"organization":[{"display":"EquiliDrugCo Inc."}]}]}